日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment beyond progression and rechallenge with pyrotinib in HER2-positive metastatic breast cancer and brain metastases: a multicenter real-world study

HER2阳性转移性乳腺癌和脑转移患者在疾病进展后接受吡咯替尼治疗及再次治疗:一项多中心真实世界研究

Peng, Jing; Chen, Qitong; Liu, Liping; Xie, Ning; Liu, Mingwen; Liu, Xuan; Qian, Liyuan; Lu, Kaili; Wu, Tao; Xie, Haiqing; Xu, Haifan; Hu, Zecheng; Ding, Sijuan; Zhou, Wei; Zhang, Chaojie; Li, Yan; Hu, Jinhui; Xie, Ruilian; He, Jing; Sun, Zhengkui; Xu, Feng; Zhang, Danhua; Long, Qian; Zhu, Jinfeng; Chen, Xi; Ouyang, Quchang; Wang, Shouman; Yi, Wenjun

CircMYH9 promotes the mRNA stability of SPAG6 by recruiting EIF4A3 to facilitate the progression of breast cancer.

CircMYH9 通过招募 EIF4A3 来促进 SPAG6 mRNA 的稳定性,从而促进乳腺癌的进展

Fan Shanji, Cui Ying, Liu Yingjie, Li Yuehua, Huang Hong, Hu Zecheng

Nicotinamide mononucleotide ameliorates ionizing radiation-induced spermatogenic dysfunction in mice by modulating the glycolytic pathway.

烟酰胺单核苷酸通过调节糖酵解途径改善电离辐射引起的小鼠精子发生功能障碍

Yang Wenqin, Nong Weihua, Liu Ke, Lei Xiaocan, Chen Xiaping, Jiang Pei, Tang Jiayi, Hu Cong, Hu Zecheng, Li Meixiang

Artemisinin ameliorates thyroid function and complications in adult male hypothyroid rats via upregulation of the L1 cell adhesion molecule

青蒿素通过上调L1细胞黏附分子,改善成年雄性甲状腺功能减退大鼠的甲状腺功能及其并发症。

Li, Lingling; Xu, Haifan; Hu, Zecheng; Li, Li

A breast cancer classification and immune landscape analysis based on cancer stem-cell-related risk panel

基于癌症干细胞相关风险面板的乳腺癌分类和免疫图谱分析

Hu, Haihong; Zou, Mingxiang; Hu, Hongjuan; Hu, Zecheng; Jiang, Lingxiang; Escobar, David; Zhu, Hongxia; Zhan, Wendi; Yan, Ting; Zhang, Taolan

Numb downregulation suppresses cell growth and is associated with a poor prognosis of human hepatocellular carcinoma

Numb基因表达下调会抑制细胞生长,并且与人类肝细胞癌预后不良相关。

Xie, Chengzhi; Lu, Zhenhui; Liu, Guoxing; Fang, Yu; Liu, Jiefeng; Huang, Zhao; Wang, Fusheng; Wu, Xiaolong; Lei, Xiaohua; Li, Xiaocheng; Zhang, Yueming; Hu, Zecheng; Qian, Ke; Hu, Jixiong; Huang, Shengfu; Zhong, Dewu; Xu, Xundi